What does Harrow, Inc. do?

Jun 22 2025 06:38 PM IST
share
Share Via
Harrow, Inc. is a pharmaceutical company specializing in ophthalmology pharmaceutical compounding, with recent net sales of $48 million and a net profit of -$18 million. The company has a market cap of approximately $1.12 billion.
Overview:
Harrow, Inc. operates in the Pharmaceuticals & Biotechnology industry, focusing on a diversified portfolio of healthcare businesses, including ophthalmology pharmaceutical compounding.

Financial Snapshot:
Most recent Net Sales: 48 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -18 Million (Quarterly Results - Mar 2025)
Market cap: USD 1,116.03 Million (Micro Cap)

Key Metrics:
Debt Equity: 2.74
Return on Equity: -37.99%
Price to Book: 19.77

Contact Details:
Address: 102 WOODMONT BLVD, SUITE 610, NASHVILLE TN: 37215
Tel: 1 615 7334731
Website: http://www.imprimisrx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News